期刊名称：JOURNAL OF THE AMERICAN HEART ASSOCIATION
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Journal of the American Heart Association
Cardiovascular and Cerebrovascular Disease
Copyright © 2013: The American Heart Association. The copyright in each Contribution published in the Journal shall be in the name of the Contributor(s) or other owner of copyright as appropriate. Compilation and layout copyright 2013 AHA
Each article is made available under the terms of the Creative Commons Attribution Non Commercial License
Instructions to Authors
JAHA Instructions for Authors
How to Prepare a Manuscript:
Article Types
JAHA publishes several types of manuscripts under the umbrella of full-length articles. A brief description of each type follows:
Original Research Articles
JAHA will consider all types of original research articles, including studies conducted with human subjects and experimental models, as well as high-quality applied clinical, epidemiological, and healthcare policy papers related to cardiovascular and cerebrovascular diseases. The journal particularly serves as a venue for papers related to the mission of each of the sixteen Scientific Councils of the American Heart Association. Specific content areas of interest are as follows: arrhythmia and electrophysiology, cardiovascular nursing, cardiovascular surgery, congenital heart disease, coronary heart disease, epidemiology, exercise physiology, genetics and translational biology, health services and outcomes research, heart failure, hypertension, imaging, interventional cardiology, molecular cardiology, nutrition, pediatric cardiology, pericardial disease, peripheral vascular disease, preventive cardiology, renal disease, resuscitation science, stroke, transplantation, valvular heart disease, and vascular medicine.
Review Series
Please note that the editors invite most review articles. However, unsolicited material will be considered for publication.
- Contemporary Reviews in Cardiovascular Medicine: Reviews will focus on topics of contemporary interest to the clinician. Overviews of natural history, diagnostic strategies, and treatment approaches will be included in this series.
- Basic Science for Clinicians: Articles will include cutting-edge reviews of the scientific basis of cardiovascular disease mechanisms and treatments, and will include molecular cardiology, genetics, genomics, physiology, and pharmacology. Emphasis will be placed on the practical application—or translation—of a contemporary understanding of basic mechanisms of disease and treatment to clinical practice.
Special Sections
- E-Letters: After reading an article, readers will be able to “send a response" from a link in the content box. When submitting a response, all readers will be asked to provide his/her name, affiliation, email address, and comments. E-Letters will be reviewed by the editors, and the editors will decide whether or not the response should be published. Published e-letters will appear at the end of the articles to which they relate. This feature will be online-only and the comments must relate to the content of the associated paper. Accepted E-letters will be collegial in tone. Lower priority will be given to comments that focus on failure to cite prior work.
- Editorials: The editors will solicit all editorials. Instructions pertaining to the writing of an editorial will be included with the request from the editorial office.
Please note that all manuscripts must conform to one of the above article types. We do not consider articles such as Case Reports for publication.
General Preparation Instructions
- Manuscript should be typed double-spaced, including title page, abstract, text, references, figure legends, and tables. Text should only appear on one side of the page. Acceptable formats are Word or WordPerfect.
- Leave a 1-inch margin on all sides. Do not use justified margins.
- Cite references, figures, and tables in numeric order. For review, acceptable figure formats are GIF, TIFF, EPS, JPEG, and single slides of PowerPoint. Formats NOT supported are as follows: Object Linking and Embedding (OLE), Bitmap (.bmp), PICT (.pict), Excel (.xls), Photoshop (.psd), Canvas (.cnv), CorelDRAW (.cdr), and locked or encrypted PDFs. Although TIFF files are allowed, please note that they often do not convert properly, so are not recommended. For publication, see acceptable figure requirements under "Accepted Manuscripts" below.
- Use SI units of measure. A more conventionally used measurement may follow in parentheses. Make all conversions before manuscript submission.
- Please provide sex-specific and/or racial/ethnic-specific data when appropriate, in describing the outcomes of epidemiologic analyses or clinical trials, or specifically state that no sex-based or racial/ethnic-based differences were present.
- Consult the American Medical Association Manual of Style, 10th ed, New York, Oxford University Press, 2007, for style.
- Manuscripts must conform to the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (http://www.icmje.org/).
- Assemble the manuscript in this order: Title Page, Abstract, Text, Acknowledgments, Funding Sources, Disclosures, References, Figure Legends, Tables, and Figures.
Title Page
The title page (page 1, do not number) should contain these elements:
- Full title
- First author’s surname and short title (not to exceed 50 characters, including spaces)
- Authors’ names, academic degrees, and affiliations
- Name and complete address for correspondence (include street name and address as well as post office box, and address for reprints if different from correspondence)
- Fax number, telephone number, and email address
- The Journal Subject Codes pertaining to the article. Please refer to the Subject Code List.
Abstract and Key Words
- Do not cite references in the abstract
- Limit use of acronyms and abbreviations. Define at first use with acronym or abbreviation in parentheses.
- Be concise (250 words maximum)
- Use the following headings:
- Background—rationale for study
- Methods and Results—brief presentation of methods and presentation of significant results; please include sample size
- Conclusions—succinct statement of data interpretation
- When applicable, include a fourth heading, "Clinical Trial Registration." Please list the URL, as well as the Unique Identifier, for the publicly accessible website on which the trial is registered.
- Insert 3 to 5 Key Words after abstract. Please refer to the Key Word List
Text
During the submission process, you will be asked to complete the AHA Open Access Agreement that requests the following information:
- Acknowledgments: Authors should obtain written permission from all individuals who are listed in the “Acknowledgments” section of the manuscript, because readers may infer their endorsement of data and conclusions. The corresponding author must sign the “Acknowledgment Section” of the Copyright Transfer Agreement, certifying that (1) all persons who have made substantial contributions in the manuscript (eg, data collection, analysis, or writing or editing assistance), but who do not fulfill authorship criteria, are named with their specific contributions in the Acknowledgments section of the manuscript; (2) all persons named in the Acknowledgments section have provided the corresponding author with written permission to be named in the manuscript; and (3) if an Acknowledgments section is not included, no other persons have made substantial contributions to this manuscript.
- Public Access Policy Fund Disclosure: You will be asked to disclose the funding source for the research on which your article is based. If your research was funded by the National Institutes of Health, the Wellcome Trust, or the Howard Hughes Medical Institute, it must be noted.
Disclosures
All potential conflicts of interest must be stated within the text of the manuscript, under this heading. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the article. Such relationships include, but are not limited to, employment by an industrial concern, ownership of stock,membership on a standing advisory council or committee, being on the board of directors, or being publicly associated with the company or its products. Other areas of real or perceived conflict of interest could include receiving honoraria or consulting fees or receiving grants or funds from such corporations or individuals representing such corporations.
Please state "None" if no conflicts exist.
References
- Accuracy of reference data is the responsibility of the author.
- Verify all references against original sources.
- List all authors for each reference; do not use “et al.”
- Example of a good reference:
- Smith HJ, Allen S, Yu W, Fard S. This is the title. Circulation. 2004;104:276-308.
Please note that if you use reference software tools (e.g., EndNote or Reference Manager), they do not always match our style and you may need to manually correct your references.
- Cite references in numeric order according to first mention in the text. In the text, ensure accuracy of spelling and details of publication, i.e., the text citation should match the reference information.
- Personal communications, unpublished observations, and submitted manuscripts are not legitimate references. They must be cited in the text only (not in the reference list) as follows: author name, degree(s) held, unpublished data, year.
- Abstracts may be cited only if they are the sole source and must be identified in the reference as “Abstract.”
- References must be from a full-length publication in a peer-reviewed journal.
- “In-press” citations must have been accepted for publication and the name of the journal or book publisher must be included.
- Figure parts should be clearly labeled. Letters and locants must be uniform in size and style within each figure, and when possible, between figures. (The font size must be 10 point or higher.)
- Avoid headings on the figure. Heading information should appear in the figure legend.
- Line art should not contain hair lines, which are hard to reproduce.
- Supply a scale bar with photomicrographs.
- Provide double-spaced copy for figure legends on a separate page.
- Symbols and abbreviations must be defined in the figure or its legend.
- Limit white space between the panel and panel label.
- Figures should be sized as close as possible to their final print size. Please note that very few figures qualify for a 2-column format.
Tables
- Begin each table on a separate page, double-spaced. Please remember that tables prepared with Excel are not accepted unless embedded within your text document.
- The table number should be Arabic, followed by a period and brief title.
- Use same size type as in text.
- Supply a brief heading for each column.
- Indicate footnotes in this order: *, †, ‡, §, ||, #, **.
- Do not use vertical lines between columns. Use horizontal lines above and below the column headings and at the bottom of the table only. Use extra space to delineate sections within the table.
- Abbreviations used in the table must be defined in a footnote to the table.
Supplemental Material
Authors are encouraged to enhance their manuscript with media files, additional images, web-based calculators, and other material that does not fit into the usual format of an online article but that helps communicate results and/or educate the reader.
Other Materials Required for Review
- A copy of all submitted manuscripts mentioned in the article must be submitted as part of the review process.
- A copy of all manuscripts, either in preparation or submitted, that potentially overlap with your JAHA submission. Please note that failure to include such material is a violation of the journal's Ethical Policy, below.
- A copy of all in-press articles cited in the Reference section must be supplied for review by the editors and the reviewers.
Ethical Policy
Manuscripts are considered on the understanding that they contain original material, that the manuscript and material within the manuscript have not been published and are not being considered for publication elsewhere in whole or in part in any language, including publicly accessible web sites or e-print servers, except as an abstract. The authors also certify that any and all other work in preparation, submitted, in press, or published that is potentially overlapping either in the actual data presented or in the conceptual approach is enclosed along with the original submission. Any material within the manuscript that has appeared elsewhere must be cross-referenced and permission to use or adapt the material must be received, in writing from the copyright holder.
Abstracts and Webcasts
If some or all of the work in the manuscript has been published or submitted in abstract form, and/or overlapping data exists, the following rules apply:
- The published or submitted abstract must accompany the submitted manuscript.
- The abstract cannot itself have been referenced in MEDLINE or PubMed.
- The potentially overlapping work and a separate explanation of the nature of any possible overlap with the submitted manuscript must accompany the submitted manuscript.
These restrictions generally do not apply to presentations or press reports published in connection with scientific meetings, or to poster presentations at scientific meetings that are videotaped, provided that the material has not been widely circulated, copyrighted or sold. Posting an audio recording, video recording, or short summary of a presentation made at a professional meeting on the Internet would be considered as a meeting presentation by the American Heart Association and would not compromise consideration of a submission. Direct release of information through press releases or media briefings may preclude publication.
Embargo Policy
All content information of an accepted paper is strictly confidential and cannot appear in the media (in print or electronic form) before its embargo date and time. Authors/researchers, their respective public relations representatives and funding sponsors may not distribute or promote their work to the media prior to embargo.
In the event that the American Heart Association/American Stroke Association selects the manuscript for promotion in a news release, news conference, video news release or podcast, AHA/ASA staff will contact the author/researcher to inform him/her of the pending news materials and to notify him/her that he/she may give reporters pre-embargo interviews based upon the media requests generated by the AHA/ASA news materials. Authors/researchers must ensure that the reporter understands and will adhere to the embargo time.
If an embargo break is the result of any action by an author/researcher, he/she risks withdrawal of publication of his/her manuscript. Violations of the embargo policy may also jeopardize future acceptance of manuscripts to be published in AHA/ASA scientific journals.
Generally, embargoes on journal articles lift the day and the time the article is published, either on-line or in print (whichever comes first) by the American Heart Association/American Stroke Association.
Questions about media embargoes should be directed to Bridgette McNeill, Senior Communications Manager, Science Media Operations, AHA National Center, 7272 Greenville Avenue, Dallas, TX 75231-4596; Tel: 214-706-1135; Email: bridgette.mcneill@heart.org.
Although the Editorial Office will endeavor to notify authors of the anticipated publication date/time, neither the Editorial Office nor the AHA/ASA will be responsible for any consequences of early online posting with regard to the intellectual property rights. To safeguard their intellectual property, authors should ensure that appropriate reports of invention and patent applications have been filed before the manuscript is accepted.
How to Submit a Manuscript:
General Online Submission Information
All manuscripts must be submitted electronically. Before proceeding to the online submission site, please prepare your manuscript according to the instructions listed above under the heading, "How to Prepare a Manuscript." When your manuscript is ready for submission, please go to http://jaha-submit.aha-journals.org/. The instructions below are meant to help guide you through the submission process.
-
Submission Files:
-
Manuscript text file
-
Tables – either embedded within the manuscript or submitted separately. Please note that, for publication purposes, all tables must be provided in an editable text format. Excel or PDF files will not be accepted.
-
Figures – either embedded or submitted separately. Please note that only PPT, EPS, or TIFF files will be allowed for publication.
-
Supplemental Files: When submitting supplemental files, please note whether or not they are intended for review purposes only or if they are intended for publication as an online data supplement.
-
For all revisions, invited de novo submissions, and uninvited resubmissions, please note that three additional files are required:
- All Author Information, including
- First and Last Names
- Affiliations
- E-mail Addresses
Submission Process
The four steps of the submission process are: Files, Manuscript Information, Validate, and Submit. The four steps each contain sub-steps that can be accessed by clicking on their respective tabs. Navigating through this "Tab View" will save any entered information each time a new tab is clicked (or the boxes "Save and Continue" and "Next" are clicked). Each step and sub-step is listed below:
- Title and Running Title (you can cut and paste this from your manuscript).Please note that you will not be allowed to exceed a 50 character limit for the short title.
- Abstract (you can cut and paste this from your manuscript) – For Original Research articles only.
- Subject Codes, Key Words, and Categories (Original Articles only) – A minimum of 1 subject code and key word is required. Only 1 category may be selected; please note that, if accepted, your manuscript will be published under the category selected here.
- Clinical Trial Registration – All clinical trials should have been registered prior to patient enrollment. If your manuscript is considered a clinical trial but has not been registered, it will not be considered for publication in the journal. You will be asked to provide the URL and identification number for the trial registration.
- Files
- Upload Files: A screen asking for the actual file locations (via an open file dialog) will appear. After completing this screen, your files will be sent to be converted to PDF for the peer review process.
- Remove Files: Allows the user to remove previously uploaded files.
- Replace Files: Allows the user to replace any previously submitted files with another file.
- File Type: This tab prompts the user to choose the "file type" that corresponds to the upload document. The five basic types of files are Author Cover Letter, Manuscript File, Figure, Table, Supplemental Material.
- File Description: When uploading a file type labeled "Figure," "Table," or "Supplemental Material," it is required to give a brief description of the content that is included in the file.
- File Order: This tab allows the user to rearrange files to be displayed at the author's discretion. This tab also gives the option to merge PDF files into a single PDF file to display to the Editor and Reviewers. Upon completion, the user must check the checkbox indicating completion of the ordering and selection process.
- Manuscript Information
- Title, Cover Title, Abstract: It is required for the user to provide a Title for the manuscript as well as a ShortTitle and an Abstract. The Short Title and Abstract have word or character limits. Invited content does not have Abstracts.
- Authors: This tab prompts the user to submit General Information about the author. The fields marked with an asterisk (*) are required, and need to be completed to continue the submission process.
- Keywords & Subject Areas: A screen where the author provides the subject areas and key words for the manuscript.
- Detailed Information: This screen asks for more detailed information regarding the manuscript, including "Clinical Trial Registration."
- Additional Information: This screen asks the author to verify that the study complies with the AHA's ethical policies.
- Author Reviewer Suggestions: This screen allows the user to provide "suggested reviewers" to include for the review process. The author can also provide reviewers to exclude from the review process.
- Review
- Approve Files: This screen allows the user to verify that the manuscript has been uploaded and converted to the PDF format correctly.
- Approve Manuscript: This screen asks the author to correct, review and approve the information entered as part of the submission process.
- Submit
- This screen is the final step of the submission process. The system will check to make sure everything is completed before the manuscript is submitted. If the manuscript is ready for submission, then there will be text that reads: "Your manuscript is ready to be submitted. Click the link below to finalize your submission." Otherwise, it will ask that you modify your submission to fulfill all of the submission requirements.
Revised Manuscripts:
- The journal is in the process of transitioning to a new peer review system. Please refer to your decision letter for instructions regarding the submission of your revision.
- Please label each page of your revision using your manuscript number followed by /R1, /R2, /R3, etc.
- Please state the comment of the reviewer, followed by your response.
- Please provide a marked-up version of the manuscript, denoting the changes that have been made in response to the previous review, as a supplemental file.
- Enter Conflict of Interest Disclosures. You will need to describe conflicts regarding this manuscript for all authors.
- Original manuscript files should be submitted electronically to the Editorial Office, so as not to delay publication if and when the paper is accepted.
Compliance With NIH and Other Research Funding Agency Accessibility Requirements
JAHA will be fully compliant with Open Access requirements of funding organizations and institutions where they apply. All articles will be freely available on HighWire, the journal’s ePublishing platform, and deposited in PubMed Central immediately on publication, as required by the National Institutes of Health, Wellcome Trust, and other Open Access funding agency mandates.
Accepted Manuscripts:
- The following are required for publication:
- Original source files for the manuscript text, tables and figures.
- Only TIFF (tagged image file format), EPS (encapsulated postscript) and PPT (Microsoft PowerPoint) files are acceptable for publication.
- Color files must be saved as RGB Red-Green-Blue.
- Line art must be saved at resolution of at least 1200 dpi; photographs, CT scans, radiographs, etc, should be saved at a resolution of at least 300 dpi. Images saved at 72 dpi are not acceptable for printed publications.
- PowerPoint files can be acceptable, although PowerPoint is not a recommended application for image preparation. Color figures submitted as PowerPoint may experience a shift in hue. PowerPoint files must contain only supported fonts (Arial, Helvetica, Times Roman, and Symbol). If other fonts are used in the PowerPoint file or in EPS files embedded in a PowerPoint document, there is a significant chance of formatting errors or character substitutions. Images must be embedded in PowerPoint files, rather than "linked".
- Each panel of the figure should be saved in a separate file.
- Prior to publication, the Open Access Agreement must be completed by each author and faxed to the editorial office. To ensure proper handling, it is suggested that the corresponding author collect the completed forms from each author and fax them, simultaneously, to the Editorial Office. A link to this form also can be found at the top of this page.
- Written permissions from all persons acknowledged by name should be collected and retained by the corresponding author.
- Payment of the Article Publication Charge.
Timely publication of a manuscript will depend upon all of the above.
Article Publication Charge to Authors
- For authors who are members of the American Heart Association, the publication charge is $1,500. Become a Member.
- For authors referred with their peer-review reports from another AHA journal, the publication charge is $1,650.
- The publication charge for authors submitting directly to the journal is $2,000.
- If articles are funded by certain Research Funding Agencies, additional discounts may apply.
Permissions
- Requests for permission to reproduce figures, tables, or portions of articles originally published in JAHA can be obtained via Rightslink (a service of the Copyright Clearance Center), not the Editorial Office. All permission requests are now processed via the Rightslink online system. Steps for obtaining permission include:
- On the JAHA home page, either search for the article using the Search feature or locate a copy of the article in the online archives for which you are requesting permission.
- Next, select the Full Text or PDF version of the article.
- Then, locate the "Request Permissions" link in the menu on the right side of the Web page (under "Services"). A new Web browser will open, which is Rightslink.
- Follow the step-by-step instructions in Rightslink for requesting permission by:
- selecting the way the content will be used.
- creating an account, if one does not exist already.
- accepting the terms and conditions for reuse.
- determining method of payment.
- Further information can be found in the Permissions and Rights Instructions.
- Note: For AHA Scientific Statements and Guidelines, permission to reprint, modify, alter, enhance, copy, or distribute this content must be obtained from the American Heart Association. Instructions are located at http://www.heart.org/HEARTORG/General/Copyright-Permission-Guidelines_UCM_300404_Article.jsp. A link to the "Permission Request Form" appears on the right side of the Web page, in the box.
Conflict of Interest Policy for Editors
Original manuscripts authored or coauthored by the Editor (in Chief), the Deputy Editor, Senior Associate Editor, or any of the Associate Editors are handled by a Consulting Editor, who makes all the decisions about the manuscript (including choice of referees and ultimate acceptance or rejection). The entire process is handled confidentially. All manuscripts submitted from the Editor's home institution are also handled entirely by a Consulting Editor. The Editor (in Chief) may additionally, from time to time, refer a manuscript to a Consulting Editor to avoid a real or reasonably perceived conflict of interest.
Disclaimer
Statements, opinions, and results of studies published in JAHA are those of the authors and do not reflect the policy or position of the American Heart Association, and the American Heart Association provides no warranty as to their accuracy or reliability.
Editorial Board
Editor-in-Chief
Joseph A. Vita, Boston University School of Medicine
Deputy Editor
Barry London, University of Iowa Carver College of Medicine
Senior Associate Editors
Daniel T. Eitzman, University of Michigan
Richard Karas, Tufts University School of Medicine
L. Kristin Newby, Duke School of Medicine
Pamela N. Peterson, University of Colorado Denver
Thomas J. Wang, Massachusetts General Hospital and Harvard Medical School
Statistical Editor
Lisa M. Sullivan, Boston University School of Public Health
Deputy Statistical Editor
Janice Weinberg, Boston University School of Public Health
Statistical Consultants
Kevin J. Anstrom, Duke University School of Medicine
Emilia Bagiella, Mount Sinai School of Medicine
Alexa Beiser, Boston University School of Public Health
Serkalem Demissie, Boston University School of Public Health
Kimberly Dukes, DM-STAT, Inc.
Andrzej S. Kosinski, Duke University School of Medicine
Michael LaValley, Boston University School of Public Health
Qi Long, Emory University
Songfeng Wang, General Dynamics Information Technology
Editorial Board
Hossein Ardehali, Northwestern University
Ivor Benjamin, University of Utah
Robert M. Bryan, Jr., Baylor College of Medicine
Holli Devon, University of California, Davis
Thomas Gerber, Mayo Clinic - Jacksonville
Mary Fran Hazinski, Vanderbilt University
John Ikonomidis, Medical University of South Carolina
Hani Jneid, Baylor College of Medicine
Julie Johnson, University of Florida
Christopher M. Kramer, University of Virginia Health System
David Pollock, Georgia Health Sciences University
Kerry-Anne Rye, The University of Sydney
U. Joseph Schoepf, Medical University of South Carolina
Joseph I. Shapiro, Marshall University
Eric E. Smith, University of Calgary
Jeffrey Towbin, Cincinnati Children's Hospital
Viola Vaccarino, Emory University
Rob Van Dam, Natoional University of Singapore and Harvard School of Public Health
Peter Wilson, Emory University
Managing Editor
Kathleen Sullivan
AHA Journal Editors
Arteriosclerosis,
Thrombosis, and
Vascular Biology
Alan Daugherty
Circulation
Joseph Loscalzo
Circulation:
Arrhythmia and
Electrophysiology
William G. Stevenson
Circulation:
Cardiovascular
Genetics
Ramachandran S. Vasan
Circulation:
Cardiovascular
Imaging
Marcelo F. Di Carli
Circulation:
Cardiovascular
Interventions
David P. Faxon
Circulation:
Cardiovascular
Quality and Outcomes
Harlan M. Krumholz
Circulation:
Heart Failure
James E. Udelson
Circulation Research
Roberto Bolli
Hypertension
Anna F. Dominiczak
JAHA—Journal
of the American
Heart
Association
Joseph A. Vita
Stroke
Marc Fisher
Scientific Publishing Committee
Robert M. Carey, MD, FAHA Chair
Richard W. Newman, Vice Chair
Cheryl Anderson, PhD, FAHA
David A. Bush
Salvador Cruz-Flores, MD, FAHA
Kathy Griendling, PhD, FAHA
Kelly A. Hadsell
Joseph A. Hill, MD, PhD, FAHA
Evangelos D. Michelakis, MD, FAHA
Alison Mudditt
Sean I. Savitz, MD, FAHA
P. K. Shah, MD
Linda Van Horn, PhD, RD
Y. Joseph Woo, MD, FAHA
|
2047-9980/asset/cover.gif?v=1&s=301dd8eb1dc0b89c64b89d9a7e259d5c8d10056f "Cover image for Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease")